Science Explorer Interactive view Map
Company · Lachen · Switzerland

Octapharma (Switzerland)

octapharma.com/en.htmlROR OpenAlex
Research works
40
▲ 51% vs 2013–17
Citations
609
15.4 per fractional work
Top-10% rate
11.9%
record average 16.5%
Open access
28%
world 28%

Not ranked overall: Octapharma (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Octapharma (Switzerland)?

Ranked on the composite score, Cristina Solomon and Sigurd Knaub lead among researchers whose main affiliation is Octapharma (Switzerland).

  1. 1 Cristina Solomon Switzerland · #364,560 worldwide 104 citations · 20 works
  2. 2 Sigurd Knaub Switzerland · #539,433 worldwide 59 citations · 15 works
All ranked researchers at Octapharma (Switzerland)

Which keywords describe research at Octapharma (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Prophylaxis, Hemostasis, Recombinant Factor VIIa, Factor VIII, Hemophilia, Microcirculation and Fibrinogen.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy7▲ 68×2 topics
  2. Prophylaxis7▲ 118×2 topics
  3. Hemostasis6▲ 109×3 topics
  4. Recombinant Factor VIIa6▲ 380×2 topics
  5. Factor VIII6▲ 926×1 topic
  6. Hemophilia6▲ 926×1 topic
  7. Microcirculation4▲ 117×2 topics
  8. Fibrinogen4▲ 295×1 topic
  9. Thrombosis4▲ 41×4 topics
  10. Transglutaminases4▲ 295×1 topic
  11. Anemia4▲ 77×3 topics
  12. Inflammation4▲ 3.7×7 topics
  13. Hemorrhage2▲ 87×2 topics
  14. Monoclonal Antibodies2▲ 43×2 topics
  15. Platelets2▲ 98×2 topics
  16. Therapeutic Antibodies2▲ 48×2 topics
  17. Immune Thrombocytopenic Purpura2▲ 142×1 topic
  18. von Willebrand Disease2▲ 142×1 topic
  19. Immune Response2▲ 8.7×5 topics
  20. Alloimmunization2▲ 128×1 topic
  21. Blood Groups2▲ 128×1 topic
  22. Blood Transfusion2▲ 89×2 topics
  23. Protein Aggregation2▲ 60×2 topics
  24. Biopharmaceuticals2▲ 63×1 topic
  25. Recombinant Proteins2▲ 81×1 topic
  26. Fetal Hydrops1▲ 175×1 topic
  27. Parvovirus B191▲ 175×1 topic
  28. Cardiac Surgery1▲ 41×1 topic
  29. Critical Care1▲ 15×2 topics
  30. Cytoreductive Surgery1▲ 49×1 topic
  31. Intraperitoneal Chemotherapy1▲ 178×1 topic
  32. Sepsis1▲ 21×2 topics
  33. Tranexamic Acid1▲ 152×1 topic
  34. Coagulopathy1▲ 38×1 topic
  35. Glycosylation1▲ 13×2 topics
  36. Trauma1▲ 16×1 topic
  37. BCR-ABL1▲ 103×1 topic
  38. Imatinib1▲ 103×1 topic
  39. E-Waste1▲ 52×1 topic
  40. Recycling1▲ 10×1 topic

Which research topics does Octapharma (Switzerland) publish most on?

By volume in 2022–2025: Hemophilia Treatment and Research, Platelet Disorders and Treatments, Blood properties and coagulation and Atrial Fibrillation Management and Outcomes.

Hemophilia Treatment and…2Hemophilia Treatment and Research: 2 fractional worksPlatelet Disorders and T…1Platelet Disorders and Treatments: 1 fractional worksBlood properties and coa…1Blood properties and coagulation: 1 fractional worksAtrial Fibrillation Management and Outcomes: 0 fractional worksHeparin-Induced Thrombocytopenia and Thrombosis: 0 fractional worksTrauma, Hemostasis, Coag…0Trauma, Hemostasis, Coagulopathy, Resuscitation: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksVenous Thromboembolism Diagnosis and Management: 0 fractional worksInflammatory Biomarkers in Disease Prognosis: 0 fractional worksIntraperitoneal and Appendiceal Malignancies: 0 fractional works
HematologyPulmonary and Respiratory MedicineCardiology and Cardiovascular MedicineSurgery3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hemophilia Treatment and Research Hematology 2 works
  2. 2 Platelet Disorders and Treatments Hematology 1 works
  3. 3 Blood properties and coagulation Pulmonary and Respiratory Medicine 1 works
  4. 4 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  5. 5 Heparin-Induced Thrombocytopenia and Thrombosis Surgery 0 works
  6. 6 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works
  7. 7 Chronic Myeloid Leukemia Treatments Hematology 0 works
  8. 8 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  9. 9 Inflammatory Biomarkers in Disease Prognosis Oncology 0 works
  10. 10 Intraperitoneal and Appendiceal Malignancies Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.8%not open72.2%

World: 28% of research is openly available.

with international co-authors70.8%domestic only29.2%

World: 19% is written across borders.

How has Octapharma (Switzerland)'s research output changed?

Output in 2018–2022 was 51% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lachen

All research institutions in Lachen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.